Theravance Biopharma
TBPH
TBPH
119 hedge funds and large institutions have $696M invested in Theravance Biopharma in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 20 closing their positions.
Holders
119
Holders Change
-3
Holders Change %
-2.46%
% of All Funds
1.92%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
18
Increased
39
Reduced
39
Closed
20
Calls
$13.2M
Puts
$1.63M
Net Calls
+$11.6M
Net Calls Change
+$6.3M
Top Buyers
1 |
ICM
1
Irenic Capital Management
New York
|
$19.1M |
2 |
2
Two Sigma Advisers
New York
|
$11.3M |
3 |
3
Two Sigma Investments
New York
|
$10.8M |
4 |
4
BlackRock
New York
|
$59.8M |
5 |
![]()
5
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$11.6M |